Phio Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 4/6
Phio Pharmaceuticals has a total shareholder equity of $3.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $5.3M and $1.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$4.70m |
| Equity | US$3.77m |
| Total liabilities | US$1.52m |
| Total assets | US$5.30m |
Recent financial health updates
Recent updates
Phio Pharmaceuticals appoints interim executive chairman
Sep 29Phio Pharmaceuticals GAAP EPS of -$0.19 beats by $0.12
Aug 11Is Phio Pharmaceuticals (NASDAQ:PHIO) In A Good Position To Deliver On Growth Plans?
Apr 11
Phio soars 22% on positive in vivo data on combination PD-1 and TIGIT therapy in cancer
Nov 09Financial Position Analysis
Short Term Liabilities: PHIO's short term assets ($5.3M) exceed its short term liabilities ($1.5M).
Long Term Liabilities: PHIO has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: PHIO is debt free.
Reducing Debt: PHIO had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PHIO has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: PHIO has less than a year of cash runway if free cash flow continues to reduce at historical rates of 6.7% each year